Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;67(3):207-10.
doi: 10.1007/s00105-015-3744-4.

[Porphyria cutanea tara]

[Article in German]
Affiliations
Review

[Porphyria cutanea tara]

[Article in German]
H F Merk. Hautarzt. 2016 Mar.

Abstract

Porphyria cutanea tara (PCT) has a prevelance of about 40 new diagnoses per 1 million people per year and is the most frequently occurring type of porphyria worldwide. Inhibition of the uroporphyrinogen decarboxylase (UROD) is the main cause of the disease, which can be the result of a heterozygous or homozygous mutation of the UROD gene; however, xenobiotics or other diseases may play an important role for the precipitation of the disease. Risk factors include alcohol, estrogen, iron overload, and hemochromatosis, hepatitis C or poisoning, e.g., with polyhalogenated aromatic compounds such as hexachlorobenzene. Signs and symptoms are blisters, skin fragility, erosions hyperpigmentation, sclerodermoid plaques. Therapy includes sun protection, prevention of risk factors, phlebotomy, and chloroquine.

Keywords: Aryl-hydrocarbon-receptor; Chloroquine; Hexachlorobenzene; Sunscreening agents; Uroporphyrinogen decarboxylase.

PubMed Disclaimer

References

    1. Ann N Y Acad Sci. 1979 May 31;320:308-10 - PubMed
    1. J Clin Invest. 1982 Jan;69(1):129-35 - PubMed
    1. J Am Acad Dermatol. 1988 Nov;19(5 Pt 1):812-9 - PubMed
    1. Tissue Antigens. 1984 Jul;24(1):67-9 - PubMed
    1. Arch Dermatol Res. 1985;277(2):114-7 - PubMed

LinkOut - more resources